News | Proton Therapy | July 30, 2018

IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan

Pair of new proton therapy systems installed in just 12 months, equaling IBA’s shortest time to completion

IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan

July 30, 2018 – IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton therapy solution in Japan. The first installation took place at the Hokkaido Ohno Memorial Hospital in Sapporo and the other at the Narita Memorial Proton Center in Toyohashi. Both installations were successful, according to the company, as the Hokkaido Ohno Memorial Hospital installation took less than 12 months and the Narita Memorial Proton Center installation took less than 11 months.

Hokkaido Ohno Memorial Hospital expects to start treating its first patient in the coming weeks, whilst Narita Memorial Proton Center plans to start treatment in September 2018.

The single room Proteus One solution, installed and maintained by IBA, offers a truly compact intensity modulated proton therapy (IMPT) system. The unique open gantry environment is designed to facilitate the treatment workflow for radiation therapists and optimize the patient experience by providing a comfortable and soothing environment. Its compact design makes it easy to install, integrate, operate and finance.

Makoto Narita, M.D., chairman, Narita Memorial Hospital in Toyohashi added: “We were able to open the Proton Therapy Center in a very small space downtown thanks to the compact design of the Proteus One manufactured by IBA. This convenient location means that outpatient treatment emphasizing social life becomes possible. We will continue working together with IBA to provide the most advanced and patient-friendly proton therapy treatment available.”
 
For more information: www.iba-worldwide.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.